Objective: Molecular analysis of the Bruton's tyrosine kinase (Btk) gene in
two unrelated families, with a combined total of seven boys, affected by X
-linked agammaglobulinaemia (XLA).
Methods: Protein electrophoresis and western blotting were used for the exa
mination of Btk protein synthesis in blood leucocytes. Isolation of the cod
ing sequence of the Btk gene was performed by amplification using the rever
se transcription-polymerase chain reaction (RT-PCR) technique. Sequence alt
erations were screened for by the single-stranded conformation polymorphism
(SSCP) method and characterized by standard sequencing protocols.
Results: Western blotting revealed Btk protein to be absent in leucocytes o
f affected males from both families. A novel 3 b.p. deletion in exon 3 of t
he Btk gene was found to be responsible for the XLA phenotype in the affect
ed proband in one family (kindred I). A diagnostic PCR assay was establishe
d to detect this mutation in other affected male siblings and carrier femal
es. For the second family (kindred II), the coding sequence of the Btk gene
and the promoter region were found to be normal.
Conclusions: The present study has demonstrated genetic heterogeneity in th
e Btk gene in South African XLA patients and has identified a novel mutatio
n in this gene in the largest of the affected kindreds. The gene mutation i
n the second kindred was undetermined and may be indicative of a defect in
some other gene associated with Btk function or stability. Western blotting
was found to be informative in establishing a deficiency of Btk protein in
both probands and is recommended as a frontline procedure in the molecular
diagnosis and work-up of XLA.